Meta-analysis of the therapeutic effects of traumatic BPPV and idiopathic BPPV - Report - MDSpire

Meta-analysis of the therapeutic effects of traumatic BPPV and idiopathic BPPV

  • By

  • Yifei Fu

  • Zhibin Zhao

  • June 9, 2026

Share

Clinical Report: Treatment Outcomes in Traumatic Versus Idiopathic BPPV

Overview

This systematic review evaluates the treatment efficacy and prognosis differences between traumatic benign paroxysmal positional vertigo (t-BPPV) and idiopathic BPPV (i-BPPV). Findings indicate that t-BPPV has significantly poorer outcomes, including higher recurrence rates and repositioning difficulties.

Background

Benign paroxysmal positional vertigo (BPPV) is a prevalent vestibular disorder that significantly impacts patients' quality of life. Understanding the differences in treatment outcomes between t-BPPV and i-BPPV is crucial for optimizing management strategies. This study addresses the need for high-level evidence to guide clinical practice in treating these distinct forms of BPPV.

Data Highlights

OutcomeRR (95% CI)p-value
Recurrence Rate3.39 (3.07–3.74)< 0.00001
Repositioning Difficulty3.05 (2.74–3.40)< 0.00001
Treatment Efficacy0.87 (0.84–0.90)< 0.00001
Multi-Semicircular Canal Involvement2.91 (1.55–5.47)0.0009
Bilateral BPPV Incidence3.37 (1.86–6.10)< 0.00001

Key Findings

  • t-BPPV has a significantly higher recurrence rate compared to i-BPPV (RR = 3.39).
  • Patients with t-BPPV experience greater repositioning difficulty (RR = 3.05).
  • The treatment efficacy for t-BPPV is lower than for i-BPPV (RR = 0.87).
  • There is a higher proportion of multi-semicircular canal involvement in t-BPPV (RR = 2.91).
  • t-BPPV shows an elevated incidence of bilateral BPPV (RR = 3.37).

Clinical Implications

Clinicians should recognize that t-BPPV presents unique challenges compared to i-BPPV, necessitating tailored management strategies. Long-term follow-up and personalized interventions are essential for improving outcomes in patients with t-BPPV.

Conclusion

The findings underscore the need for differentiated treatment approaches for t-BPPV due to its poorer prognosis compared to i-BPPV. Enhanced understanding of these differences can lead to better patient management and care.

Related Resources & Content

  1. Frontiers in Neurology, 2026 -- Risk factors for refractory BPPV: subtype-dependent association of serum 25-hydroxyvitamin D
  2. DIGITAL HEALTH, 2026 -- Analysis of the quality and reliability of benign paroxysmal positional vertigo-related short videos on TikTok and Bilibili: A cross-sectional study
  3. Utilization of Auditory Brainstem Responses in Diagnosing Neurovascular Compression of the Eighth Cranial Nerve in Vestibular Paroxysmia
  4. Journal of Neuro-Oncology, 2024 -- Tinnitus Following Vestibular Schwannoma Treatment: A Systematic Review and Comparative Study of Microsurgical and Stereotactic Radiosurgical Approaches
  5. AAO-HNS Benign Paroxysmal Positional Vertigo Guideline Summary - Guideline Central
  6. Frontiers, 2026 -- Meta-analysis of the therapeutic effects of traumatic BPPV and idiopathic BPPV
  7. Position Statement: Vestibular Rehabilitation - American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS)
  8. AAO-HNS Clinical Practice Guideline on BPPV
  9. Frontiers | Meta-analysis of the therapeutic effects of traumatic BPPV and idiopathic BPPV
  10. Position Statement: Vestibular Rehabilitation - American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS)

Original Source(s)

Related Content